Overview:
Antipsychotic drugs are thought to produce secondary negative symptoms, which can also exacerbate primary negative symptoms. In the present study we examined whether motivational deficits in particular were related to antipsychotic treatment in patients with schizophrenia in a dose-dependent fashion.
Conclusion:
Antipsychotic dose was not related to level of amotivation for any of the medications examined. Moreover, severity of sedation was not significantly related to degree of amotivation. One hundred and one individuals were identified as antipsychotic-free at baseline, and after 6 months of antipsychotic treatment no change in motivation was found.
Chronic treatment with antipsychotics does not necessarily impede or enhance goal-directed motivation in patients with schizophrenia. It is possible that the negative impact of antipsychotics in this regard is overstated; conversely, the present results also indicate that we must look beyond antipsychotics in our efforts to improve motivation.
SOURCE: